Admetsys, a company headquartered in Boston, has developed a system for controlling blood glucose levels in critical care patients. Essentially an artificial pancreas, the system relies on a lab-on-a-chip that’s embedded within an intravenous catheter to measure glucose and lactic acid, automatically supplying insulin or glucose to keep the patient within normal range.
Measurements are done about every five minutes, and since sensing is embedded there’s no blood drawn out of the patient, no fingers are pricked. Moreover, once the catheter is placed and the system is initiated, there’s nothing for a nurse to do in terms of blood sugar regulation.
The system is moving through the regulatory frameworks in the U.S. and Europe, but the company has yet to receive any approvals.
Here’s Timothy Valk, the co-founder and Chief Scientist of Admetsys, discussing the company and its technology on CNBC:
Admetsys on its artificial pancreas for treating diabetes from CNBC…
You may be interested
The Dark Tower: Stephen King explains why the movie adaptation struggled to workFrank - Feb 15, 2019
Frank's source: http://www.independent.co.uk/arts-entertainment/films/news/stephen-king-the-dark-tower-interview-review-explanation-a7969651.html
Movies you might have missed: The CruiseFrank - Feb 15, 2019
Frank's source: http://www.independent.co.uk/arts-entertainment/films/features/movies-you-might-have-missed-the-cruise-a7969891.html
I-League: Leaders Chennai City FC Held By Neroca FC In Six-Goal ThrillerFrank - Feb 15, 2019
Chennai City FC, I-League leaders, were held to a 3-3 draw by fifth-placed Neroca, blowing the title race wide open…